The novel system monitors people's movements and use of open space to provide accurate data for use in healthcare, urban planning, retail yield management, law enforcement and tourism management. The technology was developed by Dr. Noam Shoval and Michal Isaacson, of the Hebrew University’s Department of Geography.
Yissum and Makhteshim will work together on two projects. The first collaboration is for the development of a novel method for producing slow and controlled release of herbicides. The second collaboration involves a novel insecticidal preparation combining a proprietary Chitin synthesis inhibitor (CSI) and a pathogenic fungus that kills caterpillars of night-flying moths, which are major pests for agriculture worldwide.
Oral drug delivery developer Chiasma has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize its Transient Permeability Enhancer (TPE) technology.
Roche signes a collaboration agreement with Yissum and selected six projects for further research.
Fulcrum's technology was invented by Professor Oded Shoseyov and Professor Arie Altman both from the Robert H. Smith Faculty of Agriculture, Food & Environment at The Hebrew University of Jerusalem, and was licensed to Fulcrum for further development, by Yissum, the technology transfer arm of the Hebrew University.
EtoCleanTM, is a new antiviral hand sanitizer which has been found to be highly effective against the swine flu virus. The novel product was invented by Professor Elka Touitou from the School of Pharmacy, at the Hebrew University of Jerusalem and is being developed by Novel Therapeutic Technologies (NTT), a spin-off company of Yissum.
The technology, involving isolation of the stem cells from bone marrow, was developed by Dr. Zulma Gazit, Dr. Gadi Pelled, Prof. Dan Gazit and their research team at the University's Skeletal Biotechnology Laboratory, and was licensed by YIssum to US-based TheraCell Inc.
Phase I data demonstrate that Protexia(R), based on research by HUJI Prof. Hermona Soreq, is safe and well tolerated with no evidence of immunogenicity. Suggest the potential for Protexia(R) as valuable countermeasure for nerve agent exposure.
This novel method for content analysis, invented by Professor Ari Rappoport and Mr. Oren Tsur from the Hebrew University School of Computer Science and Engineering, is specifically designed to automatically rank book and product reviews according to their estimated helpfulness.
The compounds developed by Doron Steinberg, a professor in the Faculty of Dental Medicine, and Morris Srebnik, a professor in the Institute of Drug Research, and colleagues will be used to coat pipes, filters, membranes, air conditioning ducts, and other surfaces in contact with water that are prone to biofilm formation.
Read a book by light from power provided by your potato plants? That's the kind of dream Prof. Boris Rubinsky and his team think about and are at the initial stages of working on right now, along with Prof. Haim Rabinowitch, former Hebrew University rector, who invented the cherry tomato.
Under the agreement, BrightSource will fund research in the laboratories of Professors Daniel Mandler, and Shlomo Magdassi, both from the Institute of Chemistry at the Hebrew University of Jerusalem.
According to the terms of the agreement, Roche has selected six promising research projects in the fields of stem cells, biomarkers, and novel molecules for the treatment of metabolic diseases, initiated by Hebrew University researchers.
HUJI Professors Leonid Shvartsman and Boris Laikhtman have invented a novel design of TeraHertz-ray (T-ray) lasers with future applications for security cameras and spectrometers and medical imaging.
The country's first interdisciplinary center for developing drugs will be opened this week by the Hebrew University of Jerusalem on the Ein Kerem campus of its School of Pharmacy - thereby utilizing the talents and ideas of a wide variety of campus scientists and attracting financial support from donors and the pharmaceutical industry.
The Jerusalem Post: A new soundscape language has been created by an Israeli researcher that allows blind people to "see" objects, in much the same way a bat does.
Researchers at the Hebrew University and Shaarey Tzedek Hospital showed the effectiveness of using NewSit - a modification of a standard airline seat- to prevent DVT.
NewSit raises the feet from the floor, facilitates mobility, and permits intermittent calf compression.
A novel electrochemical approach for the formation of sol-gel based nanocomposite materials was developed by professors David Avnir and Daniel Mandler of the Institute of Chemistry at the Hebrew University of Jerusalem.
Biotech firm BioCancell Therapeutics Ltd. (TASE:BICL), which is developing drugs to fight cancer, said that its flagship drug BC-819 was granted orphan drug status for use against ovarian cancer. The move protects the drug from competition for at least seven years.
Research carried out at the laboratory of Prof. Hermona Soreq at The Hebrew University of Jerusalem has resulted in a promising approach to help treat Alzheimer’s disease in a significant proportion of the population that suffers from a particularly rapid development of this disease.